Going Concern, a Deep-Discount Rights Issue and an Unrenewed Anchor Contract
Northline Chemicals Ltd is a listed speciality chemicals manufacturer. Consolidated debt is Rs 1,180 crore, 62% of net worth has been eroded, and term-loan repayments of Rs 210 crore fall due in the next twelve months against forecast operating cash flow of Rs 95 crore. One lender has classified the account as SMA-2. The statutory auditor has told the audit committee that the FY2024-25 financial statements will carry a material uncertainty related to going concern paragraph unless a refinancing or equity infusion is signed before the accounts are approved. The board meets on 28 May 2025 to approve the accounts and a Rs 400 crore rights issue. The MD wants the directors' report to state that the company continues to be a going concern with no material uncertainty, and he wants the rights issue priced at Rs 55 against a market price of Rs 92, with no valuation report, so that the promoter's 74% stake is preserved. A customer contract contributing 30% of revenue is up for renewal in July on verbal assurances only.
1. Should the independent director approve the accounts and sign the directors' responsibility statement in the form the MD proposes?
Read the worked answer
Separate the accounts from the narrative. Approving accounts that carry an auditor's going concern material uncertainty paragraph is permissible if the disclosure is complete and the going concern basis is still the appropriate basis of preparation. Signing a directors' report that denies the existence of that uncertainty is a different act altogether.
The responsibility statement is a personal representation. Section 134(5) requires the directors to state, among other things, that the accounts have been prepared in compliance with the accounting standards with no material departures, and that proper care was taken for the maintenance of adequate accounting records. A known going concern uncertainty that is denied in the report is a misstatement in a statutory filing, and a director who signs it cannot shelter behind the board majority. Sections 447 and 448 create personal exposure for fraud and false statements.
The duty question under Section 166. The test is not whether the numbers can be reconciled, but whether a director acting with reasonable care and independent judgement believes the report is true. If the auditor says the uncertainty exists unless refinancing or infusion is signed, and nothing has been signed, the statement is not true.
What the director should require before signing: (1) a cash flow and covenant analysis covering the twelve months to May 2026, stress-tested for the loss of the anchor customer; (2) a written position from each lender on standstill or refinancing; (3) disclosure of the going concern uncertainty in the notes and an honest statement in the board's report consistent with those notes; (4) a board-approved remediation plan with milestones; (5) her dissent recorded in the minutes if the narrative is not corrected.
Conclusion: approve the accounts with full going concern disclosure and vote against the form of the directors' report proposed by the MD. If both are bundled in one resolution, record dissent and seek legal advice on signing.
2. What must the independent director insist on before the board approves a Rs 400 crore rights issue at Rs 55 against a market price of Rs 92?
Read the worked answer
The price and the process. A rights issue is exempt from the preferential allotment pricing formula, which is precisely why the rationale for the discount must be documented. Issuing at roughly 60% of market price transfers value to whoever subscribes; if the promoter subscribes fully and public shareholders do not, the promoter's 74% rises without any further investment in the business. The board should obtain a merchant banker's or registered valuer's opinion on fairness and record it.
The structure must be a genuine rights issue. Under Section 62(1)(a) the offer must be made to all existing equity shareholders in proportion to their holding, with the offer period and dispatch requirements met, and the explanatory statement must set out the basis of the price and the use of proceeds. If any unsubscribed portion is to be taken by the promoter outside her entitlement, that portion is a preferential allotment and attracts Section 62(1)(c) and the ICDR pricing rules.
The viability condition. A rights issue only answers the auditor's going concern point if the money will actually arrive. The board must obtain: a written and binding commitment from the promoter to subscribe to her full entitlement; a standby or underwriting arrangement for the unsubscribed portion; evidence of the promoter's funding line; and a realistic timetable that lands the funds before the next repayment date.
Use of proceeds and disclosure. Proceeds should be ring-fenced for debt repayment and working capital, not routed to repay promoter-group loans. The prior intimation to the stock exchanges and the subsequent disclosure must be made at the right time, and the letter of offer must carry the auditor's limited review.
The judgement to record: if the promoter will not commit to subscribe, the rights issue is a hope, not a refinancing, and the going concern assumption remains unsupported. That conclusion belongs in the minutes, not in a private conversation with the MD.
3. The anchor customer contract and the refinancing negotiations are both unsettled. How should the independent director handle the information and the disclosure obligations?
Read the worked answer
Identify the inside information. A contract representing 30% of revenue that may not be renewed, and a refinancing that determines whether the company remains a going concern, are both likely to be unpublished price sensitive information: they are not generally available and, if published, would probably affect the price of the securities. Verbal assurances from a customer change nothing, because the information that matters is the uncertainty itself.
Prohibit leakage and monitor trading. The director must not trade in the company's shares and must satisfy herself that the information sits on a restricted need-to-know list under the company's code of conduct, that the trading window is closed for designated persons, and that no one is discussing the rights issue price with investors or analysts before it is announced. Selective disclosure of the price or the refinancing terms breaches the prohibition on communicating unpublished price sensitive information.
Disclosure timing. Once the board resolves the rights issue, the company must disclose it promptly under the listing obligations, including the price, size and use of proceeds. On the customer contract, disclosure is required once the position crystallises, and if the renewal is refused in July that event should be disclosed within 24 hours of the company becoming aware. The director should insist that management does not wait for the quarterly results to explain a 30% revenue loss.
The governance point. Management's verbal assurances are not evidence. The board should ask for the renewal correspondence, the customer's volume forecasts and the sales team's contingency plan for a 30% revenue shortfall within the next twelve months. If that plan does not exist, it must be created before the refinancing is presented to lenders.
Personal protection. Keep a written record of what was asked, what was provided and when. In a distressed company, the paper trail is what distinguishes a director who probed from one who merely attended.